论文部分内容阅读
目的:观察普米克令舒联合博利康尼雾化吸入治疗小儿毛细支气管炎的疗效及护理。方法:随机将110例毛细支气管炎患儿分为对照组、氨茶碱控释片组、氧气驱动雾化吸入组。观察3组患儿的咳嗽、喘憋、呼吸困难和肺部哮鸣音、湿罗音。结果:氧气驱动雾化吸入组疗效高于对照组和氨茶碱控释片组。结论:普米克令舒联合博利康尼雾化吸入是缓解毛细支气管炎患儿咳嗽、喘憋、呼吸困难和肺部哮鸣音、湿罗音等症状安全有效的方法。
Objective: To observe the efficacy and nursing of pulmicort respules combibliponib aerosol inhalation in children with bronchiolitis. Methods: A total of 110 children with bronchiolitis were randomly divided into control group, aminophylline controlled-release group and oxygen-driven inhalation group. Three groups of children were observed cough, wheezing, dyspnea and lung wheeze, wet rales. Results: The oxygen-driven inhalation group had higher efficacy than the control group and the aminophylline controlled-release group. Conclusion: Pulmicort respules combined with boliconi inhalation is a safe and effective method to relieve the symptoms of cough, wheezing, dyspnea, pulmonary wheezing and wet rales in children with bronchiolitis.